Pancreatic Cancer Research

ResearcherFirst Hospital of China Medical UniversityNo recent work listed

Yuji Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-5181-1848; OpenAlex author ID A5014870760. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 2 papers · 2017: 1 paper

Papers 4

  1. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer. Co-author DOI 10.1096/fj.201601240r↗
  2. Roles of Carbonic Anhydrase IX in Development of Pancreatic Cancer. Co-author DOI 10.1007/s12253-015-9935-6↗
  3. Co-expression of FOXL1 and PP2A inhibits proliferation inducing apoptosis in pancreatic cancer cells via promoting TRAIL and reducing phosphorylated MYC. Co-author DOI 10.3892/or.2016.4592↗
  4. [Clinicopathological significance of the expression of carbonic anhydrase I and II in human pancreatic cancer]. Last author PMID 23327700↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Weiwei Sheng · 4 shared papers, 2012–2017 · strength 0.27
  2. Ming Dong · 4 shared papers, 2012–2017 · strength 0.27
  3. Yunwei Li · 2 shared papers, 2016–2017 · strength 0.14
  4. Jianping Zhou · 2 shared papers, 2012–2017 · strength 0.11
  5. Longping Huang · 1 shared paper, 2016 · strength 0.08
  6. Kewei Wang · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.